...
首页> 外文期刊>International Journal of Research in Medical Sciences >Clinical efficacy of Esmolol, Lignocaine and Diltiazem as premedicant for attenuation of hemodynamic responses of laryngoscopy and endotracheal intubation- a comparative evaluation
【24h】

Clinical efficacy of Esmolol, Lignocaine and Diltiazem as premedicant for attenuation of hemodynamic responses of laryngoscopy and endotracheal intubation- a comparative evaluation

机译:Esmolol,Lignocaine和Diltiazem作为血流动力学反应衰减血流动力学反应的临床疗效 - 比较评价

获取原文

摘要

Background: Direct laryngoscopy and endotracheal intubation after induction of anesthesia is almost always associated with hemodynamic stress response. The aim of this study was to compare esmolol, lignocaine and diltiazem for suppression of laryngoscopy and intubation response. Methods: This randomized prospective double-blind control study was performed on 120 patients of either sex, aged between 18 and 58 years of ASA physical status I and II with Mallampatti grade I and II, undergoing elective surgeries under general anesthesia with endotracheal intubation. Patients were randomized in four groups, Group N (normal saline), Group E (esmolol) 1.5mg/kg I.V, Group D (diltiazem) 0.2mg/kg I.V, and Group L (lignocaine) 1.5mg/kg I.V with 30 patients in each group. Hemodynamic parameters were recorded during the basal period, preinduction, during intubation and at specified intervals. Results: There was significant increase in systolic blood pressure, diastolic blood pressure, mean arterial pressure and heart rate in the control group (Group N) in association with tracheal intubation. The heart rate was significantly lower in Group E (Esmolol group), followed by Group D (Diltiazem group) and Group L (Lignocaine group). Rate pressure product was significantly lower in group E as compared to other groups, followed by group D and group L. Maximum increase in rate pressure product (RPP) just after laryngoscopy and intubation was ±74.29% in group N, ±16.11% in group E, 25.38% in group D and 38.77%in group L. Conclusions: Esmolol was better than diltiazem and they both were better than lignocaine for preventing the hemodynamic response after laryngoscopy and intubation.
机译:背景:诱导麻醉后直接喉镜和气管内插管几乎总是与血液动力学应激反应相关。本研究的目的是比较Esmolol,Lignocaine和Diltiazem来抑制喉镜检查和插管反应。方法:该随机预期双盲对照研究是对120例性别患者进行,年龄在18至58岁的ASA身体状况I和II之间,与Mallampatti等级I和II之间,在全身麻醉下进行的选修手提出来,通过气管插管。患者在四组中随机分组,N族(正常盐水),e(Esmolol)1.5mg / kg IV,D族(Diltiazem)0.2mg / kg IV组,Lips1(Lignocaine)1.5mg / kg IV,30名患者在每组。在基础期间,在插管期间和指定间隔期间记录血液动力学参数。结果:与气管插管相关联的收缩压,舒张压,舒张压,平均动脉压和心率显着增加。 e组(ESMOLOL组)中的心率显着降低,其次是D族(Diltiazem Group)和Lignocaine组)。与其他基团相比,速率的速率压力产品显着降低,其次是D组和L.喉镜检查后的速率压力产物(RPP)的最大增加,N族的±74.29%,组为±16.11% e,D组中的25.38%和L.组中的38.77%。结论:Esmolol优于Diltiazem,它们均优于Lignocaine,用于防止喉镜检查后血液动力学反应。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号